Clinical trial
Study of Sildenafil Citrate During and After Radiotherapy/Hormone Therapy for…
NCT00142506 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00142506 |
|---|---|
| Title | Study of Sildenafil Citrate During and After Radiotherapy/Hormone Therapy for Erectile Function Versus Radiotherapy/Hormone Therapy for Prostate Cancer |
| Official title | This Protocol is a Randomized Prospective Study Comparing Prophylactic and on Demand Sildenafil Citrate Usage Administered During and After Radiotherapy With or Without Hormone Therapy Versus Radiotherapy With or Without Hormone Therapy Alone for the Preservation of Erectile Function After Therapy… |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Collaborators | Icahn School of Medicine at Mount Sinai Beth Israel Medical Center St. Luke's-Roosevelt Hospital Center |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Prostate Cancer, Erectile Dysfunction |
| Intervention type | Drug |
| Interventions | sildenafil citrate and questionaires, placebo tablets and questionaires |
| Enrollment | 290 |
| Start date | Feb 1, 2005 |
| Primary completion | Apr 1, 2014 |
| Completion | Apr 1, 2014 |
| First posted | Sep 2, 2005 |
| Last update posted | Oct 20, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: